A recent review by researchers, including Matthew O’Connor from Cyclarity Therapeutics, highlights the multifaceted dangers of 7-ketocholesterol (7KC), an oxidized cholesterol that accumulates in cells and contributes to cardiovascular disease and neurotoxicity. The review emphasizes that 7KC not only leads to the formation of foam cells in macrophages, which exacerbate arterial plaque buildup, but also inflicts damage on neurons, promoting apoptosis and impairing mitochondrial function.

The implications of 7KC in aging and healthspan research are significant, as it serves as a potential biomarker for oxidative stress and cardiovascular risk. However, the lack of standardized measurement techniques limits its clinical utility. The authors advocate for the development of targeted therapies, specifically mentioning Cyclarity’s approach using a cyclodextrin designed to extract 7KC from cells, which is currently in Phase 1 trials.

For longevity professionals, the findings underscore the need for further exploration of 7KC’s role in disease and aging, as well as the therapeutic potential of targeted interventions. I encourage you to read the full review for a deeper understanding of these critical insights.

Source: lifespan.io